GABAergic modulation as treatment strategy: consideration of several diseases

Vlainić, Josipa (2015) GABAergic modulation as treatment strategy: consideration of several diseases. Current Pharmaceutical Design, 21 (34). pp. 4937-4938. ISSN 1381-6128

| Request a personal copy from author

Preview

PDF - Accepted Version Download (418kB) | Preview

Abstract

In the thematic issue edited the prominent authors bring novel knowledge on GABAergic system functions and give the overview of several GABA-related therapeutic options with intention to discuss evidence on the therapeutic potential and the rationale of novel GABAergic treatment of several disorders only recently connected, among others, to the abnormal function of GABAergic neurotransmission. Namely, the early clinical studies or pre-clinical evidences suggest that a promising GABAergic strategy could be developed since GABA targeting could reduce the symptoms associated with several diseases whose symptoms were recently attributed to the imbalanced inhibitory/excitatory GABA signal.

Item Type:	Article
Uncontrolled Keywords:	GABA; GABAergic system; therapy
Subjects:	BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences > Pharmacology BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences > Neuroscience BIOMEDICINE AND HEALTHCARE > Clinical Medical Sciences BIOMEDICINE AND HEALTHCARE > Clinical Medical Sciences > Clinical Pharmacology and Toxicology
Divisions:	Division of Molecular Medicine
Depositing User:	Josipa Vlainić
Date Deposited:	03 Nov 2015 15:05
URI:	http://fulir.irb.hr/id/eprint/2226
DOI:	10.2174/1381612821999150918145111

Actions (login required)

View Item